Alpha Teknova (TNKO) IPO Opens 29.5% Higher

Today's IPO for Alpha Teknova, Inc. (NASDAQ: TKNO) opened for trading at $20.72 after pricing 6,000,000 shares of its common stock at a price to the public of $16.00 per share.

Cowen and William Blair are acting as joint book-running managers for the offering. BTIG and Stephens Inc. are acting as co-managers. Paul Hastings LLP provided legal counsel to Teknova and DLA Piper LLP (US) provided legal counsel to the underwriters. Perella Weinberg Partners acted as capital markets adviser to Teknova.

Teknova is expediting clinical breakthroughs in the life sciences by providing custom products and reagents for bioprocessing, bioproduction, and molecular diagnostics. With a focus on agility and customization, Teknova delivers research-grade and GMP products including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents for a multitude of established and emerging applications, including cell and gene therapy, mRNA therapeutics, genomics, and synthetic biology. Teknova's proprietary processes enable the manufacture and delivery of high quality, custom, made-to-order products on short turnaround times and at scale across all stages of development, including commercialization.

You May Also Be Interested In

• Reformation Inc. files for IPO on NYSE under ticker REF
• JuNeng Technology files for IPO on Nasdaq at $4-$5 per share
• Gores Holdings XI closes $358.8M IPO on Nasdaq